Clinical Trial Update: Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Cytoflavin® in elderly patients to prevent cognitive decline after major surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction

Drugs mentioned

• Cytoflavin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Cognitive Dysfunction | Phase 3 | Status: COMPLETED